World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 January 2022
Main ID:  NCT03235518
Date of registration: 28/07/2017
Prospective Registration: No
Primary sponsor: Columbia University
Public title: A Combination HIV Prevention Strategy for Young Women at Risk for HIV IPrEP
Scientific title: A Combination HIV Prevention Strategy for Young Women at Risk for HIV
Date of first enrolment: June 28, 2017
Target sample size: 329
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03235518
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Kenya
Contacts
Name:     Wafaa M. El-Sadr, MD, MPH, MPA
Address: 
Telephone:
Email:
Affiliation:  Columbia University
Key inclusion & exclusion criteria

Inclusion Criteria:

FSW. Inclusion criteria for the structured interviews, FGDs and IDI are identical.

- Report being female or transgender women born make who have sex with men

- Report being HIV-negative or unknown status

- Report being between 18-24 years of age

- Report residing or working in study community

- Reports exchange sex for goods, money, flavors or other services in past 3 months

- Willing to allow audio-recording of FGDs or IDI

- Able to complete study procedures in English, Kiswahili or Dhuluo

Male Clients

- Male

- Report being >=18 years of age

- Report exchanging goods, money, favors or other services for sex in past 3 months

- Willing to allow audio-recording of IDI

- Able to complete study procedures in English, Kiswahili or Dhuluo

Health Care Providers

- Currently working as nurse or clinical officer at a clinic or other facility likely to
offer PrEP

- Report being >= 18 years of age

- Willing to allow audio-recording of IDI

- Able to complete study procedures in English

Exclusion Criteria:

- Individuals who do not meet the inclusion criteria

- Individuals who in the opinion of the investigators would interfere with adherence to
study study requirements

- FSW participating in FGD are not eligible for participation in IDI



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Human Immunodeficiency Virus
Intervention(s)
Primary Outcome(s)
Percentage of FSW participants who would be willing to participate in HIV prevention research [Time Frame: 6 months]
Secondary Outcome(s)
Percentage of MC participants who would be willing to participate in HIV prevention research [Time Frame: 6 months]
Secondary ID(s)
AAAR0256
R01MH110051
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Institute of Mental Health (NIMH)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history